Suchergebnisse - "Kissling, Esther"

PubPharm (63)

1

Effectiveness of one and two doses of acellular pertussis vaccines against laboratory-confirmed pertussis requiring hospitalisation in infants : Results of the PERTINENT sentinel surveillance system in six EU/EEA countries, December 2015 - December 2019

enthalten in: Vaccine | 2024

von Merdrignac, L. | Aït El Belghiti, F. | Pandolfi, E. | +25

2

COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022

enthalten in: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | 2024

von Lanièce Delaunay, C. | Martínez-Baz, I. | Sève, N. | +40

3

Interim 2023/24 influenza A vaccine effectiveness : VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024

enthalten in: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | 2024

von Maurel, M. | Howard, J. | Kissling, E. | +45

4

Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe : VEBIS SARI VE hospital network

enthalten in: Influenza and other respiratory viruses | 2024

von Rose, A. | Pozo, F. | Martínez-Baz, I. | +119

5

Influenza vaccine effectiveness in Europe : Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study

enthalten in: Influenza and other respiratory viruses | 2024

von Maurel, M. | Pozo, F. | Pérez-Gimeno, G. | +36

6

Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years : results from a VEBIS network, Europe, October 2021 to July 2023

enthalten in: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | 2024

von Fontán-Vela, M. | Kissling, E. | Nicolay, N. | +38

7

Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022

enthalten in: Influenza and other respiratory viruses | 2023

von Kislaya, I. | Sentís, A. | Starrfelt, J. | +32

8

Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation : I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021

enthalten in: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | 2023

von Rose, A. | Nicolay, N. | Sandonis Martín, V. | +152

9

Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation : I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022

enthalten in: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | 2023

von Rose, A. | Nicolay, N. | Sandonis Martín, V. | +159

10

Relative vaccine effectiveness of a CoronaVac booster dose in preventing symptomatic SARS-CoV-2 infection among healthcare workers during an Omicron period in Azerbaijan, January–August 2022

enthalten in: bioRxiv.org | 2023

von Finci, I. | Rojas Castro, M. | Seyidov, N. | +9

1
2
3
4
5
6
7
Nächster »
[7]